Stock GPXMED NEOLA MEDICAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Neola Medical AB

Equities

GPXMED

SE0014829255

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm
Other stock markets
 10:00:08 2024-05-17 EDT 		5-day change 1st Jan Change
2.04 SEK 0.00% Intraday chart for Neola Medical AB +6.81% +4.62%
02-14 Neola Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
2023 Neola Medical Receives New Patent Approval in Europe for the Neola Lung Monitoring System CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 56.83 54.94 28.42 108.6
Enterprise Value (EV) 1 40.19 32 -11.67 87.01
P/E ratio -6.35 x -5.47 x -3.4 x -12.1 x
Yield - - - -
Capitalization / Revenue 19.4 x 4.95 x 2.92 x 11.1 x
EV / Revenue 13.7 x 2.88 x -1.2 x 8.86 x
EV / EBITDA -5.99 x -4.82 x 1.22 x -10.6 x
EV / FCF -7,012,401 x -2,140,118 x 798,033 x -2,421,577 x
FCF Yield -0% -0% 0% -0%
Price to Book 2.41 x 1.35 x 1.11 x 1.37 x
Nbr of stocks (in thousands) 10,525 21,050 21,050 55,686
Reference price 2 5.400 2.610 1.350 1.950
Announcement Date 4/16/21 4/12/22 4/12/23 4/9/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3.145 2.83 2.923 11.1 9.743 9.825
EBITDA 1 -0.7543 -2.6 -6.709 -6.638 -9.548 -8.193
EBIT 1 -0.761 -2.606 -6.716 -6.653 -10.12 -9.626
Operating Margin -24.2% -92.09% -229.76% -59.93% -103.86% -97.97%
Earnings before Tax (EBT) 1 -0.761 -2.606 -6.717 -6.653 -10.35 -9.01
Net income 1 -0.761 -2.606 -6.717 -6.653 -10.35 -9.01
Net margin -24.2% -92.1% -229.8% -59.93% -106.26% -91.7%
EPS - -31.28 -0.8506 -0.4770 -0.3971 -0.1616
Free Cash Flow - - -5.731 -14.95 -14.63 -35.93
FCF margin - - -196.07% -134.7% -150.11% -365.71%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/6/20 4/6/20 4/16/21 4/12/22 4/12/23 4/9/24
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 9.86 5.35 16.6 22.9 40.1 21.6
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - -5.73 -15 -14.6 -35.9
ROE (net income / shareholders' equity) - -21.7% -39.2% -20.7% -19.2% -12.3%
ROA (Net income/ Total Assets) - -12.4% -22% -11.9% -10.6% -7.46%
Assets 1 - 20.98 30.56 55.84 97.53 120.8
Book Value Per Share - 129.0 2.240 1.930 1.210 1.420
Cash Flow per Share - 64.30 1.580 1.090 0.7200 0.3900
Capex - - - 0.17 0.1 -
Capex / Sales - - - 1.54% 1.06% -
Announcement Date 4/6/20 4/6/20 4/16/21 4/12/22 4/12/23 4/9/24
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Equipment

1st Jan change Capi.
NEOLA MEDICAL AB Stock Neola Medical AB
+4.62% 13.37M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.24% 12.42B
PENUMBRA, INC. Stock Penumbra, Inc.
-19.09% 7.81B
MASIMO CORPORATION Stock Masimo Corporation
+5.88% 6.4B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+13.24% 5.45B
APT MEDICAL INC. Stock APT Medical Inc.
+38.48% 5.01B
GETINGE AB Stock Getinge AB
-17.30% 4.84B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-19.78% 4.19B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-29.53% 2.69B
NOVOCURE LIMITED Stock NovoCure Limited
+47.29% 2.39B
Medical Equipment
  1. Stock Market
  2. Equities
  3. GPXMED Stock
  4. Financials Neola Medical AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW